Table 1 The epidemiology of NAFLD-associated HCC

Nov 19, 2014

10 likes | 307 Vues

Table 1 The epidemiology of NAFLD-associated HCC. Michelotti, G. A. et al. (2013) NAFLD, NASH and liver cancer Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2013.183.

Share Presentation

Embed Code

Link

nafld
2013 nafld
1038 nrgastro
liver cancer
table 1
doi 10

aline-rodriquez

Télécharger la présentation

Table 1 The epidemiology of NAFLD-associated HCC

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Table 1 The epidemiology of NAFLD-associated HCC Michelotti, G. A. et al.(2013) NAFLD, NASH and liver cancer Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2013.183

HCC INSPIRE

HCC INSPIRE. INSPIRE Goal 2: PRACTICE. QEP case study modules BIOL 1406, CHEM 1411 & PHYS 1401 Challenging, pivotal chapter Leaner-Centered Pedagogy. Texas Higher Education Coordinating Board Core Objectives. teamwork. communication. e mpirical & quantitative skills.

299 views • 16 slides

( HCC)

The Historic Crisis Committ e e. ( HCC). Executive board. Chair : Rhea Maheshwari. Director : Daanish Shastri. Rapporteur : Shaurya Taneja. About The Committee . This committee is an amalgamation of the Historic Security Council and ADHOC crisis committee .

217 views • 5 slides

Table 1 Effect size and explained variance of BMI-associated FTO SNPs

Table 1 Effect size and explained variance of BMI-associated FTO SNPs. Loos, R. J. F. & Yeo, G. S. H. (2013) The bigger picture of FTO —the first GWAS‑identified obesity gene Nat. Rev. Endocrinol. doi:10.1038/nrendo.2013.227.

126 views • 1 slides

Table 1. Demographics of the subjects

89 views • 1 slides

Uses of the HCC

Uses of the HCC. Mary Anne Cummings February 4, 2009 Fermilab AAC. Characteristics of Helical Cooling Channels. Compactness Field homogeneity (continuous solenoid) HCC theory straightforward to apply Variability in the following: Absorber Fields Channel geometry Coil construction

252 views • 15 slides

Table 1 Blood miRNA changes associated with diabetes mellitus

Table 1 Blood miRNA changes associated with diabetes mellitus. Guay, C. & Regazzi, R. (2013) Circulating microRNAs as novel biomarkers for diabetes mellitus Nat. Rev. Endocrinol. doi:10.1038/nrendo.2013.86.

93 views • 1 slides

Table 2 Distinguishing features of the subtypes of HTLV-1-associated ATLL

Table 2 Distinguishing features of the subtypes of HTLV-1-associated ATLL. Fritsch-Stork RDE et al . (2009) Rapidly fatal HTLV-1-associated T-cell leukemia/lymphoma in a patient with SLE Nat Rev Rheumatol doi:10.1038/nrrheum.2009.49.

230 views • 1 slides

The Epidemiology of Diversity in Epidemiology

The Epidemiology of Diversity in Epidemiology. History of the Minority Affairs Committee and possible future directions. Victor J. Schoenbach, Ph.D. Department of Epidemiology and Minority Health Project UNC Gillings School of Global Public Health

793 views • 61 slides

Table 1 Glomerular diseases associated with graft-versus-host disease

Table 1 Glomerular diseases associated with graft-versus-host disease. Fofi C et al. (2009) Focal segmental glomerulosclerosis as a complication of graft-versus-host disease Nat Rev Nephrol doi:10.1038/nrneph.2009.11.

205 views • 1 slides

Table 1 LUTO subtypes and associated anomalies with total prevalence

Table 1 LUTO subtypes and associated anomalies with total prevalence. Kilby, M. D. & Morris, R. K. (2014) Fetal therapy for the treatment of congenital bladder neck obstruction Nat. Rev. Urol. doi:10.1038/nrurol.2014.132.

152 views • 1 slides

Treatment of NAFLD

Treatment of NAFLD. Treatment. Weight loss Exercise Orlistat (weight loss aid) Reversible inhibitor of gastric and pancreatic lipase Bariatric Surgery Pioglitazone , Rosiglitazone Antioxidants Vit . E supplementation.

183 views • 2 slides

NAFLD

NAFLD. Dr Allister J Grant Consultant Hepatologist. How common is NAFLD?. The most common cause of abnormal liver function tests in the United States. Estimated 30.1 million with NAFLD and 8.6 million with NASH Affects 10-24% of the population 58-74% of the obese population

1.17k views • 31 slides

Table 3 Summary of infection-associated AILS cases

Table 3 Summary of infection-associated AILS cases. Prinz, J. C. (2011) Autoimmune-like syndromes during TNF blockade: does infection have a role? Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2011.35.

86 views • 1 slides

Diagnosis of HCC

Diagnosis of HCC. History & PE Serologic Assays Radiology Pathologic Diagnosis. Diagnosis of HCC: Hx & PE. History Evaluating positive predisposing factors History of hepatitis or jaundice Blood transfusion Use of intravenous drugs Family history of HCC or hepatitis Social history

238 views • 8 slides

Table 1 Milestones in HCC research reported during the past 30 years*

Table 1 Milestones in HCC research reported during the past 30 years*. Villanueva, A. et al. (2012) Medical therapies for hepatocellular carcinoma: a critical view of the evidence Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2012.199.

119 views • 1 slides

Should we undertake surveillance for HCC in patients with NAFLD ??

Should we undertake surveillance for HCC in patients with NAFLD ??. DR . Ahmed Zeid (MD) Ass.Prof . Internal Medicine HPB UNIT-Alexandria.

284 views • 25 slides

NAFLD

NAFLD. 1)Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults Dr.mousavi -Abadan- Khordad 1397.

904 views • 61 slides

Epidemiology Assignment 1

Epidemiology Assignment 1 Health-Related Quality of Life (HRQOL) Prevalence Data Trends and Analysis. Presentation Overview. Health-Related Quality of Life (HRQOL): concepts and measurement CDC HRQOL Surveillance Program’s Healthy Days Measures

148 views • 13 slides

More Related